CA2855657A1 - Systeme et methode d'augmentation de la longueur des telomeres - Google Patents

Systeme et methode d'augmentation de la longueur des telomeres Download PDF

Info

Publication number: CA2855657A1
Authority: CA; Canada
Prior art keywords: devices; electromagnetic; telomeres; aging; infrared
Prior art date: 2014-07-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2855657A

Other languages

English (en)

Inventor

Dan Grebenisan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-07-03

Filing date

2014-07-03

Publication date

2016-01-03

2014-07-03 Application filed by Individual filed Critical Individual

2014-07-03 Priority to CA2855657A priority Critical patent/CA2855657A1/fr

2015-07-02 Priority to PCT/CA2015/050612 priority patent/WO2016000075A1/fr

2016-01-03 Publication of CA2855657A1 publication Critical patent/CA2855657A1/fr

Status Abandoned legal-status Critical Current

Links

108091035539 telomere Proteins 0.000 title claims abstract description 102
102000055501 telomere Human genes 0.000 title claims abstract description 102
210000003411 telomere Anatomy 0.000 title claims abstract description 101
238000000034 method Methods 0.000 title claims abstract description 29
230000001965 increasing effect Effects 0.000 title description 11
239000013078 crystal Substances 0.000 claims abstract description 62
238000001228 spectrum Methods 0.000 claims abstract description 57
210000000349 chromosome Anatomy 0.000 claims abstract description 47
108010017842 Telomerase Proteins 0.000 claims abstract description 39
108020004414 DNA Proteins 0.000 claims abstract description 31
230000003197 catalytic effect Effects 0.000 claims abstract description 28
230000004936 stimulating effect Effects 0.000 claims abstract description 17
238000002604 ultrasonography Methods 0.000 claims abstract description 17
230000003712 anti-aging effect Effects 0.000 claims description 63
239000004744 fabric Substances 0.000 claims description 43
241001465754 Metazoa Species 0.000 claims description 20
230000003716 rejuvenation Effects 0.000 claims description 19
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 claims description 16
230000007958 sleep Effects 0.000 claims description 13
230000032683 aging Effects 0.000 claims description 12
230000008569 process Effects 0.000 claims description 8
230000004913 activation Effects 0.000 claims description 7
238000004891 communication Methods 0.000 claims description 7
239000004753 textile Substances 0.000 claims description 7
238000002329 infrared spectrum Methods 0.000 claims description 6
230000001939 inductive effect Effects 0.000 claims description 5
230000003213 activating effect Effects 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
230000036541 health Effects 0.000 claims description 4
230000007246 mechanism Effects 0.000 claims description 4
230000008093 supporting effect Effects 0.000 claims description 4
230000001976 improved effect Effects 0.000 claims description 3
238000012545 processing Methods 0.000 claims description 3
239000012774 insulation material Substances 0.000 claims description 2
230000002452 interceptive effect Effects 0.000 claims description 2
230000009977 dual effect Effects 0.000 claims 1
238000009827 uniform distribution Methods 0.000 abstract description 5
230000005686 electrostatic field Effects 0.000 abstract description 4
LAXBNTIAOJWAOP-UHFFFAOYSA-N 2-chlorobiphenyl Chemical compound ClC1=CC=CC=C1C1=CC=CC=C1 LAXBNTIAOJWAOP-UHFFFAOYSA-N 0.000 description 33
101710149812 Pyruvate carboxylase 1 Proteins 0.000 description 31
230000000694 effects Effects 0.000 description 30
230000005684 electric field Effects 0.000 description 29
210000004027 cell Anatomy 0.000 description 26
239000004020 conductor Substances 0.000 description 21
230000001276 controlling effect Effects 0.000 description 16
238000004904 shortening Methods 0.000 description 13
230000010355 oscillation Effects 0.000 description 12
238000013461 design Methods 0.000 description 10
238000004519 manufacturing process Methods 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 9
239000010453 quartz Substances 0.000 description 9
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
229910052709 silver Inorganic materials 0.000 description 9
239000004332 silver Substances 0.000 description 9
230000001225 therapeutic effect Effects 0.000 description 9
241000282412 Homo Species 0.000 description 8
239000003963 antioxidant agent Substances 0.000 description 7
235000006708 antioxidants Nutrition 0.000 description 7
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
229910052737 gold Inorganic materials 0.000 description 7
239000010931 gold Substances 0.000 description 7
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
229910052802 copper Inorganic materials 0.000 description 6
239000010949 copper Substances 0.000 description 6
230000000284 resting effect Effects 0.000 description 6
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
230000002238 attenuated effect Effects 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000032823 cell division Effects 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
230000005672 electromagnetic field Effects 0.000 description 5
230000002708 enhancing effect Effects 0.000 description 5
230000014509 gene expression Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
229910052710 silicon Inorganic materials 0.000 description 5
239000010703 silicon Substances 0.000 description 5
229910000679 solder Inorganic materials 0.000 description 5
229920000742 Cotton Polymers 0.000 description 4
241000196324 Embryophyta Species 0.000 description 4
230000003078 antioxidant effect Effects 0.000 description 4
230000005284 excitation Effects 0.000 description 4
239000011521 glass Substances 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
239000000203 mixture Substances 0.000 description 4
230000036542 oxidative stress Effects 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
230000001172 regenerating effect Effects 0.000 description 4
210000001082 somatic cell Anatomy 0.000 description 4
229910001369 Brass Inorganic materials 0.000 description 3
102100032938 Telomerase reverse transcriptase Human genes 0.000 description 3
229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 3
238000013459 approach Methods 0.000 description 3
210000003719 b-lymphocyte Anatomy 0.000 description 3
239000010951 brass Substances 0.000 description 3
230000001914 calming effect Effects 0.000 description 3
238000010586 diagram Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
239000012212 insulator Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
230000002040 relaxant effect Effects 0.000 description 3
229920002477 rna polymer Polymers 0.000 description 3
230000009758 senescence Effects 0.000 description 3
229910001220 stainless steel Inorganic materials 0.000 description 3
239000010935 stainless steel Substances 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
230000035882 stress Effects 0.000 description 3
239000000126 substance Substances 0.000 description 3
229920002994 synthetic fiber Polymers 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
239000013598 vector Substances 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
229920001410 Microfiber Polymers 0.000 description 2
102000011990 Sirtuin Human genes 0.000 description 2
108050002485 Sirtuin Proteins 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
210000001766 X chromosome Anatomy 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
239000000090 biomarker Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
239000002131 composite material Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000001955 cumulated effect Effects 0.000 description 2
230000001186 cumulative effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
235000015872 dietary supplement Nutrition 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000012772 electrical insulation material Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000035876 healing Effects 0.000 description 2
210000003958 hematopoietic stem cell Anatomy 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000009413 insulation Methods 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
239000005355 lead glass Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
239000003658 microfiber Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
-1 polyphenol compounds Chemical class 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
230000005855 radiation Effects 0.000 description 2
230000001850 reproductive effect Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
230000004622 sleep time Effects 0.000 description 2
QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
238000001845 vibrational spectrum Methods 0.000 description 2
238000004804 winding Methods 0.000 description 2
AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
AGCPZMJBXSCWQY-UHFFFAOYSA-N 1,1,2,3,4-pentachlorobutane Chemical compound ClCC(Cl)C(Cl)C(Cl)Cl AGCPZMJBXSCWQY-UHFFFAOYSA-N 0.000 description 1
WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
NMWSKOLWZZWHPL-UHFFFAOYSA-N 3-chlorobiphenyl Chemical compound ClC1=CC=CC(C=2C=CC=CC=2)=C1 NMWSKOLWZZWHPL-UHFFFAOYSA-N 0.000 description 1
206010003402 Arthropod sting Diseases 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
206010007559 Cardiac failure congestive Diseases 0.000 description 1
ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
206010014405 Electrocution Diseases 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
102000002067 Protein Subunits Human genes 0.000 description 1
108010001267 Protein Subunits Proteins 0.000 description 1
AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
101001082832 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Pyruvate carboxylase 2 Proteins 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
102000010823 Telomere-Binding Proteins Human genes 0.000 description 1
108010038599 Telomere-Binding Proteins Proteins 0.000 description 1
241001122767 Theaceae Species 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004721 adaptive immunity Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 1
229910002113 barium titanate Inorganic materials 0.000 description 1
235000021028 berry Nutrition 0.000 description 1
230000008049 biological aging Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229910052797 bismuth Inorganic materials 0.000 description 1
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
235000004883 caffeic acid Nutrition 0.000 description 1
229940074360 caffeic acid Drugs 0.000 description 1
230000025084 cell cycle arrest Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
230000010094 cellular senescence Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
235000001368 chlorogenic acid Nutrition 0.000 description 1
229940074393 chlorogenic acid Drugs 0.000 description 1
CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
235000017471 coenzyme Q10 Nutrition 0.000 description 1
ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
229920002770 condensed tannin Polymers 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
239000000428 dust Substances 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000001973 epigenetic effect Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
230000006355 external stress Effects 0.000 description 1
210000003746 feather Anatomy 0.000 description 1
235000001785 ferulic acid Nutrition 0.000 description 1
KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
229940114124 ferulic acid Drugs 0.000 description 1
KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
239000011152 fibreglass Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000006260 foam Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000003292 glue Substances 0.000 description 1
239000003163 gonadal steroid hormone Substances 0.000 description 1
230000036433 growing body Effects 0.000 description 1
230000001632 homeopathic effect Effects 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
230000001146 hypoxic effect Effects 0.000 description 1
JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 description 1
229960004135 idebenone Drugs 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000010354 integration Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000010358 mechanical oscillation Effects 0.000 description 1
230000007102 metabolic function Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
230000004089 microcirculation Effects 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
230000006855 networking Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000013021 overheating Methods 0.000 description 1
235000012771 pancakes Nutrition 0.000 description 1
208000024335 physical disease Diseases 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000007425 progressive decline Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
229910052594 sapphire Inorganic materials 0.000 description 1
239000010980 sapphire Substances 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000005476 soldering Methods 0.000 description 1
239000000243 solution Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000012209 synthetic fiber Substances 0.000 description 1
235000013616 tea Nutrition 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
239000010936 titanium Substances 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
229910052853 topaz Inorganic materials 0.000 description 1
239000011031 topaz Substances 0.000 description 1
229910052613 tourmaline Inorganic materials 0.000 description 1
239000011032 tourmaline Substances 0.000 description 1
229940070527 tourmaline Drugs 0.000 description 1
QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
230000008733 trauma Effects 0.000 description 1
229940035936 ubiquinone Drugs 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
229910000859 α-Fe Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0636—Irradiating the whole body
- A61N2005/0637—Irradiating the whole body in a horizontal position
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pathology (AREA)
Percussion Or Vibration Massage (AREA)

CA2855657A 2014-07-03 2014-07-03 Systeme et methode d'augmentation de la longueur des telomeres Abandoned CA2855657A1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
CA2855657A CA2855657A1 (fr)	2014-07-03	2014-07-03	Systeme et methode d'augmentation de la longueur des telomeres
PCT/CA2015/050612 WO2016000075A1 (fr)	2014-07-03	2015-07-02	Système et procédé d'augmentation de la longueur des télomères

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA2855657A CA2855657A1 (fr)	2014-07-03	2014-07-03	Systeme et methode d'augmentation de la longueur des telomeres

Publications (1)

Publication Number	Publication Date
CA2855657A1 true CA2855657A1 (fr)	2016-01-03

Family

ID=55018189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2855657A Abandoned CA2855657A1 (fr)	2014-07-03	2014-07-03	Systeme et methode d'augmentation de la longueur des telomeres

Country Status (2)

Country	Link
CA (1)	CA2855657A1 (fr)
WO (1)	WO2016000075A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITUA20164151A1 (it) *	2016-06-07	2017-12-07	Gianluca Spennato	Materasso e/o cuscino per magnetoterapia
CN108904995B (zh) *	2018-07-13	2023-12-19	广州易和医疗技术开发有限公司	一种多功能治疗仪
KR102209234B1 (ko) *	2018-10-02	2021-02-01	주식회사 스템온	세포의 텔로미어를 신장시키는 방법
US12241056B2 (en) *	2018-10-02	2025-03-04	Stemon Inc.	Method for extending telomere of cell
US20220073901A1 (en) *	2018-10-02	2022-03-10	Stemon Inc.	Composition for extending telomere of cell and preparation method therefor
US11316560B1 (en) *	2020-10-23	2022-04-26	Nxp B.V.	Magnetic induction device
FR3115998A1 (fr) *	2020-11-07	2022-05-13	Benjamin PONS	lit de soins pour traiter un sujet utilisant notamment l’ultrasonothérapie et la lithothérapie
CN116029216B (zh) *	2023-02-17	2023-06-09	中国石油大学(华东)	Fpso动态管缆线型智能优化方法、系统及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004058722A1 (de) *	2004-12-06	2006-06-14	Airbus Deutschland Gmbh	Sitz, Sitzbank, Fortbewegungsmittel, Magnetfeld-Resonanz-System und Verwendung einer Einrichtung zur Erzeugung einer elektromagnetischen Wechselwirkung in einem Sitz oder in einer Sitzbank

2014
- 2014-07-03 CA CA2855657A patent/CA2855657A1/fr not_active Abandoned
2015
- 2015-07-02 WO PCT/CA2015/050612 patent/WO2016000075A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2016000075A1 (fr)	2016-01-07

Legal Events

Date	Code	Title	Description
2017-01-11	FZDE	Dead	Effective date: 20161130

Publication	Publication Date	Title
TWI812157B (zh)	2023-08-11	用以對患者的身體部位提供磁性治療和射頻治療的治療裝置
WO2016000075A1 (fr)	2016-01-07	Système et procédé d'augmentation de la longueur des télomères
KR100866378B1 (ko)	2008-11-03	뇌파를 주요치료정보로 사용하는 저주파 자기물리치료장치
US11491342B2 (en)	2022-11-08	Magnetic stimulation methods and devices for therapeutic treatments
US9486638B2 (en)	2016-11-08	Thermally assisted pulsed electro-magnetic field stimulation device and method for treatment of osteoarthritis
US9636519B2 (en)	2017-05-02	Magnetic stimulation methods and devices for therapeutic treatments
US8827886B2 (en)	2014-09-09	Thermally assisted pulsed electro-magnetic field stimulation device and method for treatment of osteoarthritis
US8460167B2 (en)	2013-06-11	Thermally assisted pulsed electro-magnetic field stimulation device and method for treatment of osteoarthritis
EP2613846B1 (fr)	2022-05-11	Dispositifs de stimulation par champs électromagnétiques pulsés assisté thermiquement pour le traitement de l'arthrite
CN103585715B (zh)	2015-04-15	一种集成中频电流电场刺激设备
WO2018097185A1 (fr)	2018-05-31	Appareil de traitement du cancer
JP2011245093A (ja)	2011-12-08	超音波便秘改善器
KR20150130736A (ko)	2015-11-24	건강 매트
JP5307594B2 (ja)	2013-10-02	温熱療法用マット
CN105209114A (zh)	2015-12-30	医疗用片材的加工方法
KR101491117B1 (ko)	2015-02-10	건강 매트
JP2017094052A (ja)	2017-06-01	量子照射用ドーム
JP2017094052A5 (fr)	2017-11-09
CN202173502U (zh)	2012-03-28	用于温热电位治疗器的治疗垫
KR100603447B1 (ko)	2006-07-26	전자파 제거 기능을 갖는 돌침대
CN101432041A (zh)	2009-05-13	用于增强伤口修复的电磁治疗设备及其使用方法
KR200340133Y1 (ko)	2004-01-31	원적외선 방사 기능을 갖는 라텍스 돌 듀얼 침대
KR20250136012A (ko)	2025-09-16	파동에너지와 탄소섬유를 융합하여 인체 및 동물의 건강을 도모한 발열시트 및 웨어러블과 같은 파동발열체
JPH09234217A (ja)	1997-09-09	電気布状体
KR20130026850A (ko)	2013-03-14	저주파 패턴 발생 온열 매트